<clinical_study>
<study_id>
<org_name>
  UAarhus
</org_name>
<org_full_name>
  University of Aarhus
</org_full_name>
<org_study_id>
  20050213
</org_study_id>
<secondary_id>
  20050213 - 19/04-2006
</secondary_id>
<nct_id>
  NCT00362401
</nct_id>
</study_id>
<is_fda_regulated>
  No
</is_fda_regulated>
<brief_title>
<textblock>
  Patients Perception of Mechanical Heart Valve Sounds: Psychoacoustics and Quality of Life
</textblock>
</brief_title>
<official_title>
<textblock>
  Patients Perception of Mechanical Heart Valve Sounds: Psychoacoustics and Quality of Life
</textblock>
</official_title>
<study_sponsor>
<lead_sponsor>
<agency>
  University of Aarhus
</agency>
</lead_sponsor>
<sponsor>
<agency>
  Herz- und Diabeteszentrum Nordrhein Westfalen
</agency>
</sponsor>
</study_sponsor>
<resp_party>
<name_title>
  University of Aarhus - Thais A. Pedersen
</name_title>
<organization>
  Thais A. Pedersen - University of Aarhus
</organization>
</resp_party>
<oversight_info>
<regulatory_authority>
  Denmark: Ethics Committee
</regulatory_authority>
<has_dmc>
  No
</has_dmc>
</oversight_info>
<brief_summary>
<textblock>
The  purpose  of  this  study  is  to  compare the      sound  pressure levels (SPLs) from    three of  the most frequently implanted mechanical  heart   valve prostheses, in    order to determine whether there was any significant difference between the intensities of      the  valve  sounds 
</textblock>
</brief_summary>
<detailed_descr>
<textblock>
  Patient&apos;s perception of mechanical heart valve sounds: psychoacoustics and quality of life
 
  Background: Approximately 90.000 mechanical prosthetic heart valves are implanted every year all over the world. They generate a clicking sound at closure, which can be a major problem for some patients. About 12% of them all experience annoyance, concentration disturbance, sleeping disorders and social embarrassment. All those factors could affect patients&apos; quality of life. 
 
 Aim: to compare the   sound pressure levels (SPLs) from   three of the most frequently implanted mechanical  heart  valve  prostheses, in order to  determine whether there was any significant difference between the  intensities of        the        valve             sounds. 
 
  Material and Methods: We intended to include 150 patients with an implanted mechanical heart valve (ATS Medical, Medtronic-Hall or St. Jude Medical) in the aortic position between 3 months and 4 years before the analysis. For logistical reasons, the actual number of the patients included was 84. The total conducted valve sound was measured (by a method designed by the authors) for each patient. The measures took place in a bioacoustical laboratory built with a sound-insulated chamber with a very low background noise, designed for the purposes of the study. The measures were performed in German patients followed by &quot;The Heart Centre&quot; in Bad Oeynhausen (Herz- und Diabeteszentrum Nordrhein Westfalen, University of Bochum), where the mentioned laboratory is constructed. The sound analysis of the present study was conducted in a specially designed soundproof bioacoustic laboratory, which isolates the outside sound and vibration from the environment indoors. Inside the  laboratory, heavy soundinsulated curtains were placed between the patient
  and the investigator chambers. The total background noise inside the patient chamber was 19 dB(A), and this was reduced further to 9 dB(A) by using a 250 Hz
  high-pass filter. The sounds were recorded with the patient in the supine position, and without clothes covering the chest. The valve closing sounds were recorded using a microphone (Br&#252;el and Kj&#230;r 4179) placed 5 cm above the patient&apos;s chest. This sound was then preamplified (Br&#252;el and Kj&#230;r 2660), amplified (Br&#252;el and Kj&#230;r 2610) and 250 Hz high-pass filtered (Krohn-Hite
  3944) (see Fig. 1). All valve sounds were recorded by the same experienced investigator and stored on an instrumentation recorder (TEAC 510) for later off-line analysis. The data acquisition time for each patient was approximately 10 min.
  The patients were asked to fuldill a quality of life questionnaire (SF-36), which will be assessed in a future study regarding psychoacoustics for mechanical heart valve sounds. 
 
 
Perspectives:  The  results  obtained  from  this  analysis  will  contribute  to  expand  knowledge  concerning               the sound produced by these three different types of   mechanical heart valve prosthesis. The  study  can  add  one  important  parameter  in  the  choice  of  the  implanted  valve:  patient&apos;s pleasantness.  It  will  assess  some  of  the  most  sold  mechanical  heart  valve  worldwide  and  the  final  results  can  contribute  to  elucidate  which  type,  among  those  valves,  that  should  be  chosen  to  a  specific  patient.  
</textblock>
</detailed_descr>
<status_block>
<status>
 Completed 
</status>
<date>
2009-08 
</date>
</status_block>
<start_date>
<date>
  2005-11
</date>
</start_date>
<last_follow_up_date
 type="Actual"
>
<date>
2009-01 
</date>
</last_follow_up_date>
<phase_block>
<phase>
  Phase 0
</phase>
</phase_block>
<study_type>
  Observational
</study_type>
<design>
  Cohort
</design>
<design>
 Retrospective 
</design>
<biospec_retention>
  None Retained
</biospec_retention>
<biospec_descr>
<textblock>
</textblock>
</biospec_descr>
<number_of_groups>
  1
</number_of_groups>
<primary_outcome>
<measure>
  Intensity (Highness) of the Sound From Mechanical Heart Valves
</measure>
<time_frame>
  10.06.2007
</time_frame>
<safety_issue>
  No
</safety_issue>
</primary_outcome>
<enrollment
 type="Actual"
>
  90
</enrollment>
<condition>
  Heart Valve Diseases
</condition>
<eligibility>
<criteria>
<textblock>
  Inclusion Criteria:
-  Adult  patients  (18  years  of  age  and      older) with an  aortic  mechanical  heart  valve which  belongs  to  one  of  the  three  investigated  valve  types  and  have  been  implanted  from  three  months  to  four  years  before  the  investigation.  
 
  Exclusion Criteria:
    - Patients with severe hearing impairment (evaluated by a conventional audiogram inside the sound-insulated chamber) or who use hearing aid; 
  - patients with severe cardiac arrhythmias;
  - patients with claustrophobia;
  - patients who are not capable of cooperating to the experimental conditions at a sound-insulated chamber;
  - patients who are unable to fulfil the quality of life questionnaire.
</textblock>
</criteria>
<healthy_volunteers>
  No
</healthy_volunteers>
<gender>
  Both
</gender>
<minimum_age>
  18 Years
</minimum_age>
<maximum_age>
</maximum_age>
<study_pop>
<textblock>
  150 patients are expected to be included. They all must have a mechanical heart valve in the aortic position implanted between 3 months and 4,5 years prior to the investigation. The patients will be divided into tree main groups, which correspond to the type of valve they have acquired - ATS (ATS Medical Inc, Minneapolis, MN, USA), Medtronic-Hall&#8482; (Medtronic, Minneapolis, MN, USA) and St. Jude Medical Standard (St. Jude Medical Inc, St. Paul, MN, USA). With the purpose of recruiting a greater number of patients than those available in the geographic region of Denmark, we have established an agreement with The Heart Center in Bad Oeynhausen, Germany, who will contribute to the study with all 150 patients.
</textblock>
</study_pop>
<sampling_method>
  Non-Probability Sample
</sampling_method>
</eligibility>
<investigator>
<role>
  Principal Investigator
</role>
<name>
  Thais A. Pedersen, doctor
</name>
<affiliation>
<agency>
  Aarhus University
</agency>
</affiliation>
</investigator>
<contact>
<name>
  Thais A. Pedersen, doctor
</name>
<phone>
  +45 89495480
</phone>
<phone_ext>
</phone_ext>
<email>
  thais.a.pedersen@ki.au.dk
</email>
</contact>
<contact>
<name>
  Michael Hasenkam, Professor
</name>
<phone>
  +45 89495481
</phone>
<phone_ext>
</phone_ext>
<email>
  hasenkam@ki.au.dk
</email>
</contact>
<location>
<facility>
<name>
  Herz- und Diabeteszentrum Nordrhein Westfalen
</name>
<address>
<city>
  Bad Oeynhausen
</city>
<state>
</state>
<zip>
  32545
</zip>
<country>
  Germany
</country>
</address>
</facility>
<status>
Active, not recruiting  
</status>
<contact>
<name>
  Heinrich K&#246;rtke, doctor
</name>
<phone>
  49 ( 5731 ) 970 -
</phone>
<phone_ext>
</phone_ext>
<email>
  herzchirurgie@hdz-nrw.de
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Thais A. Pedersen, doctor
</name>
</contact>
</location>
<location>
<facility>
<name>
  Herz- und Diabeteszentrum Nordrhein Westfalen
</name>
<address>
<city>
  Bad Oeynhausen
</city>
<state>
</state>
<zip>
  32545
</zip>
<country>
  Germany
</country>
</address>
</facility>
<status>
Active, not recruiting  
</status>
<contact>
<name>
  Heinrich K&#246;rtke, doctor
</name>
<phone>
  49 ( 5731 ) 970 -
</phone>
<phone_ext>
</phone_ext>
<email>
  herzchirurgie@hdz-nrw.de
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Thais A. Pedersen, doctor
</name>
</contact>
</location>
<keyword>
  Psychoacoustics
</keyword>
<keyword>
  Quality of Life
</keyword>
<keyword>
  Heart Valve Prosthesis
</keyword>
<initial_release_date>
  2006-08-09
</initial_release_date>
<last_release_date>
2009-08-03 
</last_release_date>
<init_disposition_release_date>
</init_disposition_release_date>
<init_results_release_date>
  2009-01-22
</init_results_release_date>
<clinical_result>
<baseline>
<baselinemeasures>
<baselinemeasure>
<dispersiontype>
  Not Applicable
</dispersiontype>
<measurecategories>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  Baseline-TotalBaselineRptGroup
</reportinggroupid>
<parametervalue>
  0.0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.2
</reportinggroupid>
<parametervalue>
  0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.3
</reportinggroupid>
<parametervalue>
  0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.4
</reportinggroupid>
<parametervalue>
  0
</parametervalue>
</reportedvalue>
</reportedvalues>
<title>
  &lt;=18 years
</title>
</measurecategory>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  Baseline-TotalBaselineRptGroup
</reportinggroupid>
<parametervalue>
  36.0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.2
</reportinggroupid>
<parametervalue>
  7
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.3
</reportinggroupid>
<parametervalue>
  11
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.4
</reportinggroupid>
<parametervalue>
  18
</parametervalue>
</reportedvalue>
</reportedvalues>
<title>
  Between 18 and 65 years
</title>
</measurecategory>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  Baseline-TotalBaselineRptGroup
</reportinggroupid>
<parametervalue>
  48.0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.2
</reportinggroupid>
<parametervalue>
  8
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.3
</reportinggroupid>
<parametervalue>
  18
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.4
</reportinggroupid>
<parametervalue>
  22
</parametervalue>
</reportedvalue>
</reportedvalues>
<title>
  &gt;=65 years
</title>
</measurecategory>
</measurecategories>
<parametertype>
  Number
</parametertype>
<title>
  Age Categorical
</title>
<unitofmeasure>
  participants
</unitofmeasure>
</baselinemeasure>
<baselinemeasure>
<dispersiontype>
  Standard Deviation
</dispersiontype>
<measurecategories>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  Baseline-TotalBaselineRptGroup
</reportinggroupid>
<dispersionspread>
  9
</dispersionspread>
<parametervalue>
  63
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.2
</reportinggroupid>
<dispersionspread>
  7
</dispersionspread>
<parametervalue>
  65
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.3
</reportinggroupid>
<dispersionspread>
  9
</dispersionspread>
<parametervalue>
  64
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.4
</reportinggroupid>
<dispersionspread>
  10
</dispersionspread>
<parametervalue>
  63
</parametervalue>
</reportedvalue>
</reportedvalues>
</measurecategory>
</measurecategories>
<measuredescription>
</measuredescription>
<parametertype>
  Mean
</parametertype>
<title>
  Age Continuous
</title>
<unitofmeasure>
  years
</unitofmeasure>
<othertitle>
</othertitle>
</baselinemeasure>
<baselinemeasure>
<dispersiontype>
  Not Applicable
</dispersiontype>
<measurecategories>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  Baseline-TotalBaselineRptGroup
</reportinggroupid>
<parametervalue>
  21.0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.2
</reportinggroupid>
<parametervalue>
  7
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.3
</reportinggroupid>
<parametervalue>
  6
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.4
</reportinggroupid>
<parametervalue>
  8
</parametervalue>
</reportedvalue>
</reportedvalues>
<title>
  Female
</title>
</measurecategory>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  Baseline-TotalBaselineRptGroup
</reportinggroupid>
<parametervalue>
  63.0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.2
</reportinggroupid>
<parametervalue>
  8
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.3
</reportinggroupid>
<parametervalue>
  23
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.4
</reportinggroupid>
<parametervalue>
  32
</parametervalue>
</reportedvalue>
</reportedvalues>
<title>
  Male
</title>
</measurecategory>
</measurecategories>
<parametertype>
  Number
</parametertype>
<title>
  Gender, Male/Female
</title>
<unitofmeasure>
  participants
</unitofmeasure>
</baselinemeasure>
<baselinemeasure>
<dispersiontype>
  Not Applicable
</dispersiontype>
<measurecategories>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  Baseline-TotalBaselineRptGroup
</reportinggroupid>
<parametervalue>
  84.0
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.2
</reportinggroupid>
<parametervalue>
  15
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.3
</reportinggroupid>
<parametervalue>
  29
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  Baseline-BaselineRptGroup.4
</reportinggroupid>
<parametervalue>
  40
</parametervalue>
</reportedvalue>
</reportedvalues>
<title>
  Germany
</title>
</measurecategory>
</measurecategories>
<parametertype>
  Number
</parametertype>
<title>
  Region of Enrollment
</title>
<unitofmeasure>
  participants
</unitofmeasure>
</baselinemeasure>
</baselinemeasures>
<baselinereportinggroups>
<baselinereportinggroup
 id="Baseline-BaselineRptGroup.2"
>
<description>
<textblock>
  patients with an ATS mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<subjectsanalyzed>
  15
</subjectsanalyzed>
<title>
  ATS (Open Pivot&#174; Standard)
</title>
</baselinereportinggroup>
<baselinereportinggroup
 id="Baseline-BaselineRptGroup.3"
>
<description>
<textblock>
  patients with a Medtronic Hall mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<subjectsanalyzed>
  29
</subjectsanalyzed>
<title>
  Medtronic Hall
</title>
</baselinereportinggroup>
<baselinereportinggroup
 id="Baseline-BaselineRptGroup.4"
>
<description>
<textblock>
  patients with a St Jude Medical mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<subjectsanalyzed>
  40
</subjectsanalyzed>
<title>
  St Jude Medical
</title>
</baselinereportinggroup>
</baselinereportinggroups>
<totalbaselinereportinggroup
 id="Baseline-TotalBaselineRptGroup"
>
<subjectsanalyzed>
  84
</subjectsanalyzed>
<title>
  Total
</title>
</totalbaselinereportinggroup>
</baseline>
<certainagreement>
<otherdetails>
</otherdetails>
<pisponsoremployee>
  No
</pisponsoremployee>
<restrictiontype>
</restrictiontype>
<restrictiveagreement>
  No
</restrictiveagreement>
</certainagreement>
<lastupdatetimestamp>
  2009-08-03T07:55:02-04:00
</lastupdatetimestamp>
<outcomemeasures>
<outcomemeasure>
<dispersiontype>
  Standard Deviation
</dispersiontype>
<measurecategories>
<measurecategory>
<reportedvalues>
<reportedvalue>
<reportinggroupid>
  OutcomeMeasure.1-OutcomeRptGroup.2
</reportinggroupid>
<dispersionspread>
  5
</dispersionspread>
<parametervalue>
  43
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  OutcomeMeasure.1-OutcomeRptGroup.3
</reportinggroupid>
<dispersionspread>
  4
</dispersionspread>
<parametervalue>
  41
</parametervalue>
</reportedvalue>
<reportedvalue>
<reportinggroupid>
  OutcomeMeasure.1-OutcomeRptGroup.4
</reportinggroupid>
<dispersionspread>
  4
</dispersionspread>
<parametervalue>
  40
</parametervalue>
</reportedvalue>
</reportedvalues>
</measurecategory>
</measurecategories>
<measuredescription>
<textblock>
  The measurements took place in a Bioacoustic laboratory. The total background noise was 9 dB(A). The valve closing sounds were recorded by a microphone placed 5 cm above the patient&#8217;s chest. This sound was pre-amplified, amplified, filtered and stored on an instrumentation recorder for later off-line analysis.
</textblock>
</measuredescription>
<parametertype>
  Mean
</parametertype>
<timeframe>
  10.06.2007
</timeframe>
<title>
  Intensity (Highness) of the Sound From Mechanical Heart Valves
</title>
<unitofmeasure>
  dB (decibel)
</unitofmeasure>
<anticipatedresultpostingdate>
<month>
  01
</month>
<year>
  2009
</year>
</anticipatedresultpostingdate>
<measuretype>
  Primary
</measuretype>
<outcomemeasureanalyses>
<measureanalysis>
<outcomereportinggroups>
<outcomereportinggroupid>
  OutcomeMeasure.1-OutcomeRptGroup.2
</outcomereportinggroupid>
<outcomereportinggroupid>
  OutcomeMeasure.1-OutcomeRptGroup.3
</outcomereportinggroupid>
<outcomereportinggroupid>
  OutcomeMeasure.1-OutcomeRptGroup.4
</outcomereportinggroupid>
</outcomereportinggroups>
<cilowerlimit>
</cilowerlimit>
<cipctvalue>
  95
</cipctvalue>
<ciupperlimit>
</ciupperlimit>
<dispersiontype>
</dispersiontype>
<dispersionvalue>
</dispersionvalue>
<estimatecomment>
</estimatecomment>
<groupdescription>
<textblock>
  The comparison of the three valve groups with respect to the objective sound measures was made by the one-way ANOVA method. The null hypothesis is that there is no difference on intensity of heart valve sounds among the three groups.
</textblock>
</groupdescription>
<noninferioritytestcomment>
</noninferioritytestcomment>
<othermethodname>
</othermethodname>
<othertypename>
</othertypename>
<parametertype>
</parametertype>
<parametervalue>
</parametervalue>
<pvalue>
  &lt;0.05
</pvalue>
<pvaluecomment>
</pvaluecomment>
<statisticalmethod>
  ANOVA
</statisticalmethod>
<statisticaltestcomment>
</statisticaltestcomment>
<testednoninferiority>
  No
</testednoninferiority>
</measureanalysis>
</outcomemeasureanalyses>
<outcomereportinggroups>
<outcomereportinggroup
 id="OutcomeMeasure.1-OutcomeRptGroup.2"
>
<description>
<textblock>
  patients with an ATS mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<subjectsanalyzed>
  15
</subjectsanalyzed>
<title>
  Group 1 - ATS
</title>
</outcomereportinggroup>
<outcomereportinggroup
 id="OutcomeMeasure.1-OutcomeRptGroup.3"
>
<description>
<textblock>
  patients with a Medtronic Hall mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<subjectsanalyzed>
  29
</subjectsanalyzed>
<title>
  Group 2- Medtronic Hall
</title>
</outcomereportinggroup>
<outcomereportinggroup
 id="OutcomeMeasure.1-OutcomeRptGroup.4"
>
<description>
<textblock>
  patients with a St Jude Medical mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<subjectsanalyzed>
  40
</subjectsanalyzed>
<title>
  Group 3 - St Jude Medical
</title>
</outcomereportinggroup>
</outcomereportinggroups>
<populationanalysisdescription>
<textblock>
  Patients with a mechanical heart valve prosthesis recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</populationanalysisdescription>
<reportingstatus>
  Posted
</reportingstatus>
<safetyissue>
  No
</safetyissue>
</outcomemeasure>
</outcomemeasures>
<participantflow>
<participantflowgroups>
<flowgroup
 id="ParticipantFlow-ParticipantFlowGroup.2"
>
<description>
<textblock>
  patients with an ATS mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<title>
  ATS (Open Pivot&#174; Standard)
</title>
</flowgroup>
<flowgroup
 id="ParticipantFlow-ParticipantFlowGroup.3"
>
<description>
<textblock>
  patients with a Medtronic Hall mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<title>
  Medtronic Hall
</title>
</flowgroup>
<flowgroup
 id="ParticipantFlow-ParticipantFlowGroup.4"
>
<description>
<textblock>
  patients with a St Jude Medical mechanical heart valve recruited from a cardiology outpatient clinic following heart valve replacement at the same hospital between three months and four years prior to this investigation.
</textblock>
</description>
<title>
  St Jude Medical
</title>
</flowgroup>
</participantflowgroups>
<periods>
<period>
<completedmilestone>
<milestoneachievements>
<milestoneachievement>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.2
</reportinggroupid>
<comment>
</comment>
<subjectsachieve>
  15
</subjectsachieve>
</milestoneachievement>
<milestoneachievement>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.3
</reportinggroupid>
<comment>
</comment>
<subjectsachieve>
  29
</subjectsachieve>
</milestoneachievement>
<milestoneachievement>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.4
</reportinggroupid>
<comment>
</comment>
<subjectsachieve>
  40
</subjectsachieve>
</milestoneachievement>
</milestoneachievements>
</completedmilestone>
<dropwithdrawreasons>
</dropwithdrawreasons>
<milestones>
</milestones>
<otherparticipantflowdetails>
<otherdetail>
<numbernotcompleted>
  0
</numbernotcompleted>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.2
</reportinggroupid>
</otherdetail>
<otherdetail>
<numbernotcompleted>
  0
</numbernotcompleted>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.3
</reportinggroupid>
</otherdetail>
<otherdetail>
<numbernotcompleted>
  0
</numbernotcompleted>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.4
</reportinggroupid>
</otherdetail>
</otherparticipantflowdetails>
<startedmilestone>
<milestoneachievements>
<milestoneachievement>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.2
</reportinggroupid>
<comment>
</comment>
<subjectsachieve>
  15
</subjectsachieve>
</milestoneachievement>
<milestoneachievement>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.3
</reportinggroupid>
<comment>
</comment>
<subjectsachieve>
  29
</subjectsachieve>
</milestoneachievement>
<milestoneachievement>
<reportinggroupid>
  ParticipantFlow-ParticipantFlowGroup.4
</reportinggroupid>
<comment>
</comment>
<subjectsachieve>
  40
</subjectsachieve>
</milestoneachievement>
</milestoneachievements>
</startedmilestone>
<title>
  Overall Study
</title>
</period>
</periods>
<preassignmentdescription>
<textblock>
  3 previously included patients were excluded from the analysis due to double mechanical heart valve prosthesis (in both mitral and aortic position).
</textblock>
</preassignmentdescription>
<recruitmentdetails>
<textblock>
  All 84 included patients were recruited from the same out patient clinic at the Heart Center, Bad Oeynhausen, Germany. They have been recruited between november 2005 and april 2006.
</textblock>
</recruitmentdetails>
</participantflow>
<pointofcontact>
<email>
  thais.a.pedersen@ki.au.dk
</email>
<organizationname>
  Aarhus University Hospital, Skejby
</organizationname>
<phoneextension>
</phoneextension>
<phonenumber>
  +45 8949 5484
</phonenumber>
<title>
  Dr. Thais A. Pedersen, primary investigator
</title>
</pointofcontact>
<recordstatus>
  RELEASED
</recordstatus>
</clinical_result>
</clinical_study>
